InspireMD, Inc. (NSPR)

InspireMD Statistics

Total Valuation

InspireMD has a market cap or net worth of $79.04 million. The enterprise value is $53.62 million.

Market Cap	79.04M
Enterprise Value	53.62M

Important Dates

The last earnings date was Friday, May 9, 2025, before market open.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

InspireMD has 30.64 million shares outstanding. The number of shares has increased by 48.89% in one year.

Current Share Class	30.64M
Shares Outstanding	30.64M
Shares Change (YoY)	+48.89%
Shares Change (QoQ)	+2.26%
Owned by Insiders (%)	23.76%
Owned by Institutions (%)	24.67%
Float	17.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.97
Forward PS	9.52
PB Ratio	2.73
P/TBV Ratio	2.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	7.63
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.36, with a Debt / Equity ratio of 0.06.

Current Ratio	4.36
Quick Ratio	3.86
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -113.95% and return on invested capital (ROIC) is -70.54%.

Return on Equity (ROE)	-113.95%
Return on Assets (ROA)	-58.16%
Return on Invested Capital (ROIC)	-70.54%
Return on Capital Employed (ROCE)	-119.95%
Revenue Per Employee	$81,709
Profits Per Employee	-$420,221
Employee Count	86
Asset Turnover	0.17
Inventory Turnover	2.13

Taxes

In the past 12 months, InspireMD has paid $59,000 in taxes.

Income Tax	59,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.44% in the last 52 weeks. The beta is 0.62, so InspireMD's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+15.44%
50-Day Moving Average	2.67
200-Day Moving Average	2.75
Relative Strength Index (RSI)	48.71
Average Volume (20 Days)	50,624

Short Selling Information

The latest short interest is 181,090, so 0.59% of the outstanding shares have been sold short.

Short Interest	181,090
Short Previous Month	191,929
Short % of Shares Out	0.59%
Short % of Float	1.04%
Short Ratio (days to cover)	3.70

Income Statement

In the last 12 months, InspireMD had revenue of $7.03 million and -$36.14 million in losses. Loss per share was -$0.79.

Revenue	7.03M
Gross Profit	1.51M
Operating Income	-37.55M
Pretax Income	-25.46M
Net Income	-36.14M
EBITDA	-37.24M
EBIT	-37.55M
Loss Per Share	-$0.79

Balance Sheet

The company has $26.09 million in cash and $1.64 million in debt, giving a net cash position of $24.45 million or $0.80 per share.

Cash & Cash Equivalents	26.09M
Total Debt	1.64M
Net Cash	24.45M
Net Cash Per Share	$0.80
Equity (Book Value)	28.35M
Book Value Per Share	0.95
Working Capital	24.78M

Cash Flow

In the last 12 months, operating cash flow was -$25.60 million and capital expenditures -$1.57 million, giving a free cash flow of -$27.16 million.

Operating Cash Flow	-25.60M
Capital Expenditures	-1.57M
Free Cash Flow	-27.16M
FCF Per Share	-$0.89

Margins

Gross Margin	21.43%
Operating Margin	-534.35%
Pretax Margin	-513.45%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

InspireMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.89%
Shareholder Yield	n/a
Earnings Yield	-46.29%
FCF Yield	-34.79%

Analyst Forecast

The average price target for InspireMD is $4.50, which is 74.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	74.42%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on April 27, 2021. It was a reverse split with a ratio of 0.0666666667:1.

Last Split Date	Apr 27, 2021
Split Type	Reverse
Split Ratio	0.0666666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1